Abstract
Conjugate to ameliorate! Polymeric drug delivery using a synthetic tubulysin analogue in C26 tumor bearing mice is described. A single dose of this conjugate (shown) resulted in a 90 % increase in the average lifespan of the mice as compared to groups given a phosphate-buffered saline control or the free tubulysin analogue. Moreover, 37 % of the mice given the polymeric formulation were tumor free at the conclusion of the study.
Original language | English (US) |
---|---|
Pages (from-to) | 49-53 |
Number of pages | 5 |
Journal | ChemMedChem |
Volume | 6 |
Issue number | 1 |
DOIs | |
State | Published - Jan 3 2011 |
Keywords
- Antitumor agents
- Colon carcinoma
- Dendrimers
- Drug delivery
- Tubulysins
ASJC Scopus subject areas
- Drug Discovery
- General Pharmacology, Toxicology and Pharmaceutics
- Molecular Medicine
- Biochemistry
- Pharmacology
- Organic Chemistry